医院药师主导的降钙素原方案实施效果回顾性分析
该研究在医疗中心医院开展回顾性分析,比较药师主导的降钙素原方案实施前后对疑似或确诊脓毒症或下呼吸道感染患者降钙素原检测规范性和抗菌药物管理的影响。共纳入400例患者,结果显示方案实施后初始降钙素原检测的适当率、停药时检测率及抗菌药物适当停药率均显著提高,平均抗菌治疗天数减少。
要点
- 药师主导方案实施后初始降钙素原检测适当率从28%升至72%(P<0.001)。
- 停药时检测降钙素原的比例从8%升至37%(P<0.001)。
- 抗菌药物适当停药率从12%升至46%(P<0.001),平均抗菌治疗天数从9.17天降至6.01天(P<0.001)。
核心结论
- 实施全院药师主导的降钙素原方案提高了初始降钙素原检测的适当率,并改善了抗菌药物停药时机和缩短了抗菌治疗天数。
- 降钙素原检测需在抗菌治疗期间的正确时间点开具才能发挥抗菌药物管理作用。
研究设计与样本
- 回顾性药物使用评价,在Medical Center Hospital开展,比较方案实施前后患者结局,共纳入400例疑似或确诊脓毒症或下呼吸道感染且使用降钙素原检测的患者。
主要发现
- 方案实施后初始降钙素原检测适当率为72%(n=144),高于实施前的28%(n=56),P<0.001。
- 方案实施后停药时检测降钙素原的比例为37%(n=74),高于实施前的8%(n=16),P<0.001。
- 方案实施后抗菌药物适当停药率为46%(n=77),高于实施前的12%(n=21),P<0.001。
- 方案实施后平均抗菌治疗天数为6.01天,短于实施前的9.17天,P<0.001。
临床怎么用
- 药师可主导制定降钙素原使用方案,规范初始检测和停药时检测的时机,以促进抗菌药物合理停用。
- 对于疑似或确诊脓毒症或下呼吸道感染患者,按方案在特定时间点检测降钙素原有助于缩短抗菌治疗疗程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Procalcitonin is a precursor hormone to calcitonin that increases in response to systemic inflammation, especially of bacterial origin, and is otherwise undetectable in healthy states. Studies have shown that following effective antimicrobial treatment, procalcitonin levels steadily decline. To be utilized however, procalcitonin levels determinations must be ordered at specific times during a patient's antimicrobial treatment. A retrospective medication-use evaluation of patients was performed at Medical Center Hospital and showed that in 70% of patients, initial procalcitonin levels were ordered inappropriately and procalcitonin levels were trended inconsistently during antibiotic treatment. METHODS: A pharmacist-led procalcitonin protocol was developed and presented to medical staff committees for approval. Data was collected from patients presenting with suspected or confirmed sepsis or lower respiratory tract infections for whom procalcitonin levels were utilized. Patient outcomes before and after protocol implementation were compared. RESULTS: A total of 400 patients were included in the study. The primary outcome of appropriate ordering of initial procalcitonin levels was improved in the postprotocol group relative to the preprotocol group (28% of patients [n = 56] vs 72% of patients [n = 144]; P < 0.001). Patients in the postprotocol group had a procalcitonin level checked at discontinuation more frequently (8% [n = 16] vs 37% [n = 74], P < 0.001) and had a higher rate of appropriate discontinuation of antibiotics (12% [n = 21] vs 46% [n = 77]; P < 0.001). The postprotocol group also had fewer mean days of antibiotic therapy (9.17 vs 6.01; P < 0.001). CONCLUSION: Studies have shown the usefulness of procalcitonin levels for antimicrobial stewardship, but for procalcitonin testing to be properly utilized it must be ordered at the correct times during the patient's therapy. The implementation of a hospital-wide pharmacist-led protocol resulted in an increase in appropriate ordering of baseline procalcitonin levels.
引用
- Cowey CK, Wilson E. A retrospective analysis of the impact of a hospital pharmacist-led procalcitonin protocol. Am J Health Syst Pharm. 2022. PMID: 34752615. doi:10.1093/ajhp/zxab413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。